Active, not recruitingPhase 2NCT01176006
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
Studying Hyper-IgE syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Corina E Gonzalez, M.D.National Cancer Institute (NCI)
- Intervention
- Reduced-intensity hematopoietic stem cell(procedure)
- Enrollment
- 70 enrolled
- Eligibility
- 4-120 years · All sexes
- Timeline
- 2010 – 2026
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01176006 on ClinicalTrials.gov